TSANZ Symposium: Hot off the press – respiratory research updates
Tracks
TSANZ Symposia
Tuesday, March 25, 2025 |
8:30 AM - 10:00 AM |
E1 |
Speaker
Prof Anne Holland
Head Of Respiratory Research
Monash University / Alfred Health
Transforming pulmonary rehabilitation to reduce hospital admissions in COPD
8:30 AM - 8:50 AMBiography
Anne Holland is Professor of Physiotherapy and Head of Respiratory Research at Monash University in Melbourne, Australia. She leads a research program that aims to improve the lives of people with chronic lung disease using non-pharmacological treatments. Anne is an NHMRC Leadership Fellow.
Dr Keshav Raj Paudel
Postdoctoral Researcher
University of Technology Sydney
Defining and treating the physiological effects of bushfire smoke exposure
8:50 AM - 9:10 AMBiography
Keshav Raj Paudel is a mid-career researcher working in the field of chronic respiratory disease, exploring the disease progression and pharmacological activity of drug candidates on various lung diseases (lung cancer, asthma, and COPD) using molecular, immunological, and biochemical assays. Dr Paudel has an interest in exploring the cell signaling pathways of various inflammation-related disorders. Currently, he is involved in an Australian MRFF, NHMRC-HEAL network-funded project to explore the impact of bushfire smoke on respiratory health.
Prof Vanessa McDonald
Professor
University of Newcastle
Centre of Research Evidence for Asthma Treatable Traits (CREATT)
9:10 AM - 9:30 AMBiography
Vanessa McDonald is a Professor of Nursing in the School of Nursing and Midwifery at the University of Newcastle, Australia and an honorary clinical nurse consultant in the Department of Respiratory and Sleep Medicine at John Hunter Hospital. She is Director of the Centres of Excellence in Treatable Traits, and the Hunter Medical Research Institute’s Asthma and Breathing Programme.
Her research interests are centred around the development of innovative approaches to the management of chronic airway diseases. She is passionate about the development and implementation of personalised medicine strategies that place the person at the centre of health care delivery.
Over >25 years Vanessa has developed expertise in respiratory clinical nursing practice and education, has contributed extensively to respiratory health advocacy and health policy and, has developed as an internationally recognised respiratory researcher. She is committed to committed to improving the health and quality of life of people with lung disease in our region and internationally, and to the mission of lung health.
Prof Yuben Moodley
Professor
University of Western Australia
Treatable Traits in Interstitial Lung Disease (TTRILD) study: The new frontier
9:30 AM - 9:50 AMBiography
Professor Yuben Moodley is the head of the Cell Biology at the Institute for Respiratory Health, a Consultant Respiratory Physician at Fiona Stanley Hospital and Professor of Respiratory Medicine at the University of Western Australia.
His research interests include finding biomarkers for disease prognosis and response and investigating the pathogenesis of interstitial lung diseases. Furthermore, his team are examining the of epigenetics in lung diseases and the optimization of patient care by focusing on treatable traits. They are using stem cells and organoids to model chronic lung diseases and are presently developing new treatment targets in Idiopathic Pulmonary Fibrosis.
Assoc Prof Edward Fysh
Respiratory Physician
Sir Charles Gairdner Hospital
Chairperson
Biography
Dr Fysh is a Respiratory Physician and Intensive Care Consultant based in Perth with a special interest and research program in Pleural Disease.
Assoc Prof Cecilia Prêle
Principal Research Fellow
Institute for Respiratory Health
Chairperson
Biography
